Filing Details
- Accession Number:
- 0000899243-22-019397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-24 19:00:23
- Reporting Period:
- 2022-05-20
- Accepted Time:
- 2022-05-24 19:00:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1635088 | Roivant Sciences Ltd. | ROIV | Pharmaceutical Preparations (2834) | 981173944 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1750094 | Matthew Gline | C/O Roivant Sciences Ltd. 11-12 St. James'S Square, Ste 1, 3Rd Fl London X0 SW1Y 4LB | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2022-05-20 | 139,791 | $3.70 | 1,264,657 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
Billionaire Hedge Funds
